These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

828 related articles for article (PubMed ID: 25555122)

  • 1. Primitive neuroectodermal tumors of the brainstem in children treated according to the HIT trials: clinical findings of a rare disease.
    Friedrich C; Warmuth-Metz M; von Bueren AO; Nowak J; Bison B; von Hoff K; Pietsch T; Kortmann RD; Rutkowski S
    J Neurosurg Pediatr; 2015 Mar; 15(3):227-35. PubMed ID: 25555122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of children with central nervous system primitive neuroectodermal tumors/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapy.
    Gerber NU; von Hoff K; Resch A; Ottensmeier H; Kwiecien R; Faldum A; Matuschek C; Hornung D; Bremer M; Benesch M; Pietsch T; Warmuth-Metz M; Kuehl J; Rutkowski S; Kortmann RD
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):863-71. PubMed ID: 24969797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy.
    Friedrich C; von Bueren AO; von Hoff K; Gerber NU; Ottensmeier H; Deinlein F; Benesch M; Kwiecien R; Pietsch T; Warmuth-Metz M; Faldum A; Kuehl J; Kortmann RD; Rutkowski S
    Neuro Oncol; 2013 Feb; 15(2):224-34. PubMed ID: 23223339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial.
    Grundy RG; Wilne SH; Robinson KJ; Ironside JW; Cox T; Chong WK; Michalski A; Campbell RH; Bailey CC; Thorp N; Pizer B; Punt J; Walker DA; Ellison DW; Machin D;
    Eur J Cancer; 2010 Jan; 46(1):120-33. PubMed ID: 19818598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curative treatment for central nervous system medulloepithelioma despite residual disease after resection. Report of two cases treated according to the GPHO Protocol HIT 2000 and review of the literature.
    Müller K; Zwiener I; Welker H; Maass E; Bongartz R; Berthold F; Pietsch T; Warmuth-Metz M; von Bueren A; Rutkowski S
    Strahlenther Onkol; 2011 Nov; 187(11):757-62. PubMed ID: 22037651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving of therapeutic strategies for CNS-PNET.
    Massimino M; Gandola L; Biassoni V; Spreafico F; Schiavello E; Poggi G; Pecori E; Vajna De Pava M; Modena P; Antonelli M; Giangaspero F
    Pediatr Blood Cancer; 2013 Dec; 60(12):2031-5. PubMed ID: 23852767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adults with CNS primitive neuroectodermal tumors/pineoblastomas: results of multimodal treatment according to the pediatric HIT 2000 protocol.
    Friedrich C; Müller K; von Hoff K; Kwiecien R; Pietsch T; Warmuth-Metz M; Gerber NU; Hau P; Kuehl J; Kortmann RD; von Bueren AO; Rutkowski S
    J Neurooncol; 2014 Feb; 116(3):567-75. PubMed ID: 24407732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy.
    Massimino M; Gandola L; Spreafico F; Luksch R; Collini P; Giangaspero F; Simonetti F; Casanova M; Cefalo G; Pignoli E; Ferrari A; Terenziani M; Podda M; Meazza C; Polastri D; Poggi G; Ravagnani F; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1031-7. PubMed ID: 16343801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.
    Strother D; Ashley D; Kellie SJ; Patel A; Jones-Wallace D; Thompson S; Heideman R; Benaim E; Krance R; Bowman L; Gajjar A
    J Clin Oncol; 2001 May; 19(10):2696-704. PubMed ID: 11352962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy for brain tumors in infants and young children.
    Iwama J; Ogiwara H; Kiyotani C; Terashima K; Matsuoka K; Iwafuchi H; Morota N
    J Neurosurg Pediatr; 2015 May; 15(5):488-92. PubMed ID: 25723725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
    Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
    Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
    Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
    Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of outcome and prognostic factors in thoracic primitive neuroectodermal tumor: a study of 84 cases.
    Biswas B; Agarwala S; Shukla NK; Deo S; Sharma D; Thulkar S; Vishnubhatla S; Bakhshi S
    Ann Thorac Surg; 2013 Dec; 96(6):2006-14. PubMed ID: 24035307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors.
    Allen JC; Donahue B; DaRosso R; Nirenberg A
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1155-61. PubMed ID: 8985038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy.
    Reddy AT; Janss AJ; Phillips PC; Weiss HL; Packer RJ
    Cancer; 2000 May; 88(9):2189-93. PubMed ID: 10813733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ependymoblastoma of the brainstem: MRI findings and differential diagnosis.
    Nowak J; Seidel C; Pietsch T; Friedrich C; von Hoff K; Rutkowski S; Warmuth-Metz M
    Pediatr Blood Cancer; 2014 Jun; 61(6):1132-4. PubMed ID: 24464920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant brainstem tumors in children, excluding diffuse intrinsic pontine gliomas.
    Klimo P; Nesvick CL; Broniscer A; Orr BA; Choudhri AF
    J Neurosurg Pediatr; 2016 Jan; 17(1):57-65. PubMed ID: 26474099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
    Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
    Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
    Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy for pediatric central nervous system tumors: a regional cancer centre experience.
    Bauman G; Fisher B; Cairney E; Ranger A; Dar AR; Ross J; Stitt L; MacDonald D
    J Neurooncol; 2004 Jul; 68(3):285-94. PubMed ID: 15332333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.